Torrid, Circana and PwC Executives Discuss How GLP-1s Are Impacting Retail

- Topic
- Retail
- Source
- Retail TouchPoints
- Published
This summary was written by ShopDigest AI from Retail TouchPoints’s report, by Kate Robertson. Read the full story ↗
GLP-1 adoption has doubled in 16 months. Circana, PwC and Torrid executives explain how the shift is reshaping grocery, apparel and returns — and why one major retailer says it isn't seeing the impact at all.
Overview
GLP-1 medication adoption has more than doubled since January 2025, now reaching one in five U.S. households, according to PwC research. This shift is reshaping grocery baskets, apparel spending, and return policies, with retailers like Torrid and The Vitamin Shoppe adjusting strategies. Executives from Circana and PwC discuss the implications for ecommerce and physical retail.
Key Details
- Household GLP-1 usage grew from 9% to 21% since January 2025.
- Grocery spending per household drops 5.5% after 6–8 months on GLP-1s; protein and fiber purchases rise.
- Apparel spending among GLP-1 users increases 9.9% after 6–8 months, with jeans up 66.1% and swimwear up 31.1%.
- 73% of users report a change in clothing size, complicating sizing and returns.
- Torrid, a plus-size retailer, is monitoring the trend but not seeing major impact yet.
Why It Matters
Retailers must adapt assortments, sizing, and return policies as customer bodies and buying habits shift. Brands that ease the shopping transition for GLP-1 users may gain loyalty, while those ignoring the trend risk inventory mismatches and returns.